News & Articles
Selected Filters:
Boost your research with these upcoming expert webinars
This week, explore topics ranging from checkpoint inhibitor therapies to TIRF microscopy and automated liquid chromatography
African trial of novel HIV vaccine candidate starts
Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic
Accurate ligand high-affinity determination
Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy
New publications confirm Paragon Genomics CleanPlex SARS-CoV-2 Panel enables accurate identification of variants of concern
Continued emergence of SARS-CoV-2 variants highlights importance of sequencing for accurate COVID-19 tracking and surveillance
Harnessing the power of cell-based assays: New tools and techniques in 2021
From tackling COVID-19 variants to therapeutic discovery, novel organoids and more, advance your assay research with these exclusive interviews and free resources
Researchers develop a promising new therapy to tackle metabolic liver disease, NASH
Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis
Bio-Techne and PROGEN introduce new Simple Plex AAV2 immunoassay
The Simple Plex AAV2 assay combines the scalability and automation of Ella with best-in-class AAV reagents from PROGEN
Dante Labs to process 50,000 Covid-19 tests per day at ex-Lighthouse Lab site at Charnwood Campus
The company seeks to become a global centre of excellence for whole genome sequencing
New imaging system brings brains into sharper focus
Accelerated production of novel immunotherapies with high-throughput screening
Dr. Dallas Flies, Vice President, Discovery Research, NextCure, Inc. discusses the cutting-edge technology transforming the identification of new targets for the development of effective immunotherapeutics
ERS Genomics and Japan SLC sign CRISPR/Cas9 license agreement
Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models
Cachexia exacerbates bone resorption in cancer patients
Team at the Karl Landsteiner University of Health Sciences in Krems identifies strong correlation between cachexia and markers of bone loss
Sherlock Biosciences announces initial results of automation study with NorDx Laboratories on CRISPR-based test for SARS-CoV-2
Leading clinical laboratory runs first-ever successful automation of a CRISPR test for high-throughput, using Sherlock’s SARS-CoV-2 process
CNS inflammation: Reducing time to optimal therapy with syndromic testing
Clinical microbiology and virology expert shares her formula for success when diagnosing and treating conditions such as meningitis and encephalitis
Cell couriers deliver clue to cancer metastasis
Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells
Longer interval between Pfizer vaccine doses boosts immunity
Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells
High blood sugar levels ‘reprogramme’ stem cells
Findings explain higher risk of heart attack in people with diabetes, even after treatment
FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine
The drug aims to treat patients with myelodysplastic syndromes
Seegene introduces new SARS-CoV-2 variants detection test
The multiplex PCR test is capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases
World‘s first automated High Throughput Tissector launched by medtech innovator Xyall
The High Throughput Tissector (HT) delivers faster, more accurate and efficient tissue dissection
























